Drugs / DC Ova
last change Aug 2008 re-read 3 minutes ago

DC Ova

Vaccine

Developed for
ovarian cancer · primary peritoneal carcinoma
Investigated by
Fox Chase Cancer Center · University of Pennsylvania

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00478452 Aug 2005 → Aug 2008 fallopian tube cancer, ovarian cancer, primary peritoneal carcinoma University of Pennsylvania Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DC Ova “DC Ova vaccine administered day 2 and week 3,6,9” NCT00478452 ↗
1

NCT00478452 ↗

Modality Vaccine “multivalent DC vaccine” NCT00478452 ↗